Patent · US Expired

NK-1 receptor active amine oxide prodrugs

US6593472B2 · kind B2 · utility

53Cited by

3References

17Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Torsten Hoffmann · Weil am Rhein, DE
Sonia Maria Poli · Basel, CH
Patrick Schnider · Bottmingen, CH
Andrew Sleight · Riedisheim, FR

Key dates

Filing date	Jul 12, 2001
Grant date	Jul 15, 2003
Priority date	—
Expiry date	Jul 12, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.